AI21 is bringing AI into the 21st century, developing AI systems with an unprecedented capacity to understand and generate natural language.

Alike develops an AI-based system that helps patients monitor their own condition.

AppsFlyer is a mobile ad attribution platform that allows advertisers to analyze which campaigns drive results. AppsFlyer empowers marketers to grow their business and innovate with a suite of comprehensive measurement and analytics solutions. Built around privacy by design, AppsFlyer takes a customer-centric approach to help 12,000+ brands and 5,000+ technology partners make better business decisions every day.

Aquant’s Service Co-Pilot platform helps enterprise organizations reduce service costs, improve customer experiences, and identify the best solution to any service-related issue. Using a service domain-specific natural language processing model, Aquant’s best practice engine mines service data, including work orders, logs, manuals, and notes. Then, it improves AI performance by converting expert knowledge into synthetic data, training Service Co-Pilot to adapt based on feedback rather than hard-coded workflows. Aquant empowers every stakeholder (e.g., the end customer, contact center agent, or field technician) to diagnose and resolve problems like an expert. The platform enables business leaders to analyze service performance trends and make strategic decisions informed by data.

CyberArmor empowers DevOps teams to seamlessly deploy natively zero-trust workloads across all environments. CyberArmor provides a Zero-Trust Identity based service-to-service visibility and security control plane for cloud native, data center and hybrid environments. The CyberArmor control plane brings together data protection and workload protection by arming every workload with infrastructure-independent self-protecting capabilities assuring continuous workload authorization from CI/CD to Runtime and allowing complete visibility and control over Data, API and Network access. The company patent-pending technology utilizes stealth coding and moving target defense mechanisms to assure a strong Code-DNA based cryptographic identity and data protection throughout the entire workload lifecycle.

Avantis is a technology company specializing in seamless, profitable and efficient monetization suites for software, mobile and website owners. While generating profits that surpass expectation, the Company's technologies increase productivity and provide powerful analytics to optimize campaigns across all digital media and accelerate revenue generating opportunities. Founded in 2012 and backed by Israeli-based VC Pitango, the company has over 150 talented and dedicated employees including seasoned professionals from the industry. For more information, please contact us at: www.avantisteam.com Follow us on Facebook: http://www.facebook.com/AvantisTeam Follow us on Twitter: http://twitter.com/AvantisTeam

BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developed the ISS, based on a miniature electrode implanted at the roof of the mouth in a bed side, minimally invasive, local anesthesia procedure comparable to dental treatment. In 2008, the company completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. In 2011 the Company completed a 300 patients RCT pivotal trial that further substantiated the safety and efficacy of its treatment for acute ischemic stroke patients. BrainsGate is currently running the ImpACT-24b, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24-hour window.

CLEW Medical specializes in providing healthcare providers and administrators with high-accuracy predictive clinical analytics. Their innovative analytics engine detects deterioration in real-time and delivers predictive warnings during all phases of a patient’s ICU stay. Driven by innovative prediction models derived from Big Data analysis and an advanced high-dimensional analytics technique, CLEW's predictive platform has the flexibility to manage large patient populations without losing individualized treatment needs. CLEW's team represents decades of success in assisting healthcare institutions and other enterprises achieve their goals by exploiting breakthrough research and technologies.

The Future of Behavioral Data Convizit is an AI-driven “data-as-a-service” solution that automatically captures user events and sends property-rich behavioral data to your platforms of choice, with little or no effort on your part. Convizit’s AI automates the collection of behavioral data from your website or SaaS application, enriches event data with relevant properties, and delivers this data stream directly into your analytics, CDP and marketing platforms. With Convizit, you have access to the full power of behavioral data, without the need to plan, select, name, code or tag events. Business users can easily select and customize how the data is delivered, using a friendly user interface that requires no technical knowledge. The conventional approach to instrumenting (coding/tagging) the capture of digital behavioral activity data typically requires weeks or months of manual effort and reliance on developers. Meanwhile, the results are partial, unreliable over time and require never-ending maintenance. By automatically capturing, enriching and structuring user interactions, Convizit’s platform is disrupting how digital behavior data is collected and leveraged. Website owners and SaaS vendors alike can now exploit the full power of reliable behavioral data, with little or no effort. There is no faster, easier or more comprehensive approach to unlocking the untapped potential of analytics, BI, CDP, marketing, personalization and other data-driven platforms. In 2020, Convizit raised $5 million from Pitango Venture Capital and is now actively expanding its first-class team of developers, engineers and data scientists who are disrupting one of the oldest and largest Internet arenas.

CyberMDX is an IOT security leader dedicated to protecting the quality care of health delivery worldwide. CyberMDX provides cloud-based cybersecurity solutions that support the advancement of The Internet of Medical Things. The CyberMDX solution identifies endpoints and assesses vulnerabilities to detect, respond to, and prevent cyber incidents. Deployed worldwide, CyberMDX is designed to integrate with our customers' existing environments through its scalable, easy-to-deploy and agentless solution.

D-ID’s groundbreaking technology produces photos and videos which are unrecognizable to face recognition algorithms, while keeping them similar to the human eye. D-ID enables companies, security agencies and governments to comply with regulations and protect biometric databases.

DouxMatok is a food-tech company. They have developed a proprietary technology that enhances the sweetness of sugars with no after taste - preserving the full "sugar experience" customers are looking for. The enhanced sweetness allows for a significant reduction in the consumption of sugar. The company was incorporated in 2014, and its R&D center is based in Petach-Tikva, Israel.